BCM
PGNX

Bayesian Capital Management’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Bayesian Capital Management’s Portfolio PGNX Stock Details PGNX Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-37,900
Closed -$283K – 805
2018
Q1 		$283K Buy
+37,900
New +$283K 0.07% 411